A detailed history of Sweet Financial Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sweet Financial Partners, LLC holds 25,515 shares of PFE stock, worth $679,209. This represents 0.17% of its overall portfolio holdings.

Number of Shares
25,515
Previous 25,443 0.28%
Holding current value
$679,209
Previous $711,000 3.8%
% of portfolio
0.17%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$27.7 - $31.39 $1,994 - $2,260
72 Added 0.28%
25,515 $738,000
Q2 2024

Jul 18, 2024

BUY
$25.26 - $29.6 $22,759 - $26,669
901 Added 3.67%
25,443 $711,000
Q1 2024

Apr 23, 2024

BUY
$25.89 - $29.73 $156,013 - $179,152
6,026 Added 32.54%
24,542 $681,000
Q4 2023

Jan 12, 2024

BUY
$26.13 - $33.94 $205,329 - $266,700
7,858 Added 73.73%
18,516 $533,000
Q3 2023

Oct 23, 2023

BUY
$32.09 - $37.51 $3,690 - $4,313
115 Added 1.09%
10,658 $353,000
Q2 2023

Jul 24, 2023

SELL
$36.12 - $41.79 $11,558 - $13,372
-320 Reduced 2.95%
10,543 $386,000
Q1 2023

Apr 14, 2023

SELL
$39.39 - $51.28 $6,223 - $8,102
-158 Reduced 1.43%
10,863 $443,000
Q4 2022

Jan 19, 2023

SELL
$41.75 - $54.5 $6,220 - $8,120
-149 Reduced 1.33%
11,021 $0
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $436,112 - $532,383
-9,966 Reduced 47.15%
11,170 $489,000
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $124,886 - $148,076
2,684 Added 14.55%
21,136 $1.11 Million
Q1 2022

Apr 22, 2022

BUY
$45.75 - $56.69 $431,056 - $534,133
9,422 Added 104.34%
18,452 $955,000
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $373,119 - $553,087
9,030 New
9,030 $533,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sweet Financial Partners, LLC Portfolio

Follow Sweet Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sweet Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sweet Financial Partners, LLC with notifications on news.